Literature DB >> 3079660

Psychosocial benefits of a cancer support group.

E N Cain, E I Kohorn, D M Quinlan, K Latimer, P E Schwartz.   

Abstract

Many clinicians use group support to reduce the psychosocial difficulties of persons with cancer. This study compared the long-term benefits of a thematic counseling model used both as a structure for group support and for counseling patients individually. The thematic model included eight counseling sessions focused on information about cancer and positive health strategies such as progressive relaxation, diet, and exercise. The psychosocial status of women newly diagnosed with gynecologic cancer was assessed before the counseling, immediately after counseling, and again 6 months later. The women who participated in thematic counseling were significantly less depressed and less anxious and had more knowledge of their illness, better relationships with care givers, fewer sexual difficulties, and more participation in leisure activities. Data confirmed the model to be equally helpful whether it was used as a structure for individual counseling or more cost-effective group counseling. This model is easily adaptable to the needs of persons with other forms of cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3079660     DOI: 10.1002/1097-0142(19860101)57:1<183::aid-cncr2820570135>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Exploring the efficacy of support groups for men with prostrate cancer.

Authors:  B A Weber; B L Roberts; G J McDougall
Journal:  Geriatr Nurs       Date:  2000 Sep-Oct       Impact factor: 2.361

Review 3.  Psychological interventions for cancer patients to enhance the quality of life.

Authors:  B L Andersen
Journal:  J Consult Clin Psychol       Date:  1992-08

4.  Higher-intensity exercise helps cancer survivors remain motivated.

Authors:  Eric Martin; Claudio Battaglini; Beth Hands; Fiona L Naumann
Journal:  J Cancer Surviv       Date:  2015-11-19       Impact factor: 4.442

5.  Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer.

Authors:  Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart
Journal:  Psychooncology       Date:  2011-07-12       Impact factor: 3.894

6.  A person-centered intervention targeting the psychosocial needs of gynecological cancer survivors: a randomized clinical trial.

Authors:  Mette Linnet Olesen; Anne-Katrine Duun-Henriksen; Helena Hansson; Bent Ottesen; Klaus Kaae Andersen; Vibeke Zoffmann
Journal:  J Cancer Surviv       Date:  2016-02-22       Impact factor: 4.442

7.  Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial.

Authors:  Barbara L Andersen; William B Farrar; Deanna M Golden-Kreutz; Ronald Glaser; Charles F Emery; Timothy R Crespin; Charles L Shapiro; William E Carson
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

8.  Psychosocial intervention for rural women with breast cancer: The Sierra-Stanford Partnership.

Authors:  Karyn L Angell; Mary Anne Kreshka; Rebecca McCoy; Patricia Donnelly; Julie M Turner-Cobb; Kathy Graddy; Helena C Kraemer; Cheryl Koopman
Journal:  J Gen Intern Med       Date:  2003-07       Impact factor: 5.128

9.  Support group programme for relatives of terminally ill cancer patients.

Authors:  Asa Witkowski; Maria E Carlsson
Journal:  Support Care Cancer       Date:  2004-03       Impact factor: 3.603

10.  Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer.

Authors:  William Breitbart; Barry Rosenfeld; Hayley Pessin; Allison Applebaum; Julia Kulikowski; Wendy G Lichtenthal
Journal:  J Clin Oncol       Date:  2015-02-02       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.